Back

National Estimates for the Percentage of all Readmissions With Demographic Features, Morbidity, Overall and Gender-specific Mortality of Transcutaneous vs Open Surgical Tricuspid Valve Replacement/Repair.

Khan, M. S.; Baqi, A.; Ghumman, G. M.; Ullah, W.; Shah, J.; Sattar, Y.; Mir, T.; Sheikh, Z.; Tahir, A.; Salman, F.; Baghal, M.; Luthra, K.; Khatri, V.; Waqar, Z.; Taleb, M.; Ali, S. S.

2023-04-26 cardiovascular medicine
10.1101/2023.04.25.23289124 medRxiv
Show abstract

AimsTo determine national estimates for the percentage of all readmissions with demographic features, length of stay, cost analysis, comorbidities, overall and gender-specific mortality and complications of transcutaneous Tricuspid replacement/repair [TTVR] vs. open surgical tricuspid valve replacement/repair [Open TVR]. MethodsData was extrapolated from the NRD databases 2015-19. Of the 75,266,750 (unweighted) cases recorded in the 2015 - 2019 dataset, 429 had one or more of the percutaneous approach codes as per the ICD-10 data set, and 10077 had one or more of the open approach codes. ResultsOverall, the number of cases performed each year through open TVR was higher than TTVR, but there was an increased trend towards the TTVR every passing year. TTVR was performed more in females and advanced age groups than open TVR. The length of stay and cost was lower in the TTVR group than in open TVR. Patients undergoing TTVR had more underlying comorbidities like CHF, HTN, and uncomplicated DM. Overall mortality was 3.49 % in TTVR vs. 6.09% in open TVR. Gender-specific analysis demonstrated higher female mortality in the open TVR compared to TTVR (5.45% vs. 3.03 %). Male mortality was statistically insignificant between the two groups (6.8%% vs. 4.3%, p-value 0.15%). Patients with TTVR had lower rates of complications than open TVR, except for arrhythmias, which were higher in TTVR. Patients undergoing open TVR required more intracardiac support, such as IABP and Impella, than TTVR. ConclusionTranscatheter tricuspid valve replacement/repair is an emerging alternative to open surgical repair/replacement in patients with tricuspid valve diseases, especially tricuspid regurgitation. Despite having more underlying comorbidities, the TTVR group had lower in- hospital mortality, hospital cost, length of stay, and fewer complications than open TVR.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Open Heart
19 papers in training set
Top 0.1%
14.5%
2
Heart
10 papers in training set
Top 0.1%
14.2%
3
The American Journal of Cardiology
15 papers in training set
Top 0.2%
8.3%
4
PLOS ONE
4510 papers in training set
Top 24%
7.1%
5
Journal of the American Heart Association
119 papers in training set
Top 1%
6.7%
50% of probability mass above
6
Journal of Clinical Medicine
91 papers in training set
Top 0.6%
6.2%
7
International Journal of Cardiology
13 papers in training set
Top 0.1%
3.5%
8
BMC Cardiovascular Disorders
14 papers in training set
Top 0.5%
3.5%
9
BMJ Open
554 papers in training set
Top 7%
2.7%
10
Cureus
67 papers in training set
Top 2%
2.7%
11
Circulation
66 papers in training set
Top 1%
2.3%
12
Frontiers in Cardiovascular Medicine
49 papers in training set
Top 2%
1.9%
13
Scientific Reports
3102 papers in training set
Top 59%
1.7%
14
Journal of the American College of Cardiology
12 papers in training set
Top 0.4%
1.6%
15
European Heart Journal
16 papers in training set
Top 0.4%
1.6%
16
Heart Rhythm
22 papers in training set
Top 0.5%
1.2%
17
Circulation: Heart Failure
14 papers in training set
Top 0.4%
1.2%
18
The Journal of Heart and Lung Transplantation
10 papers in training set
Top 0.2%
1.1%
19
Nature Communications
4913 papers in training set
Top 61%
0.8%
20
PLOS Medicine
98 papers in training set
Top 4%
0.8%
21
European Heart Journal - Digital Health
15 papers in training set
Top 0.6%
0.7%
22
European Respiratory Journal
54 papers in training set
Top 2%
0.7%
23
Healthcare
16 papers in training set
Top 2%
0.7%
24
European Journal of Preventive Cardiology
13 papers in training set
Top 1%
0.7%
25
BMJ
49 papers in training set
Top 1%
0.7%
26
Vaccine
189 papers in training set
Top 2%
0.7%
27
Medicine
30 papers in training set
Top 3%
0.6%